PRELIMINARY RESULTS WITH FLUPHENAZINE (PROLIXIN) IN CHRONIC PSYCHOTIC PATIENTS
Abstract
Fluphenazine is a highly potent psychopharmacologic agent which is effective in controlling behavioral symptoms in chronic psychotic patients with the most pronounced changes manifested in reduced agitation and tension and improved socialization; the drug is also effective in controlling hallucinations and delusions. Through greater individualization of dosage may be required with fluphenazine than with other phenothiazines for maximum benefit with minimum reactions, fluphenazine appears to have great potential usefulness in the treatment of chronic psychotic patients.
Access content
To read the fulltext, please use one of the options below to sign in or purchase access.- Personal login
- Institutional Login
- Sign in via OpenAthens
- Register for access
-
Please login/register if you wish to pair your device and check access availability.
Not a subscriber?
PsychiatryOnline subscription options offer access to the DSM-5 library, books, journals, CME, and patient resources. This all-in-one virtual library provides psychiatrists and mental health professionals with key resources for diagnosis, treatment, research, and professional development.
Need more help? PsychiatryOnline Customer Service may be reached by emailing [email protected] or by calling 800-368-5777 (in the U.S.) or 703-907-7322 (outside the U.S.).
